A Kenyan court has suspended Nairobi's data-sharing deal with Washington after legal challengers argued it fails to protect patient privacy, the latest twist in a monthslong standoff over US aid terms that has divided African governments. BBC

The agreements at issue tie continued American funding to access to health data, pathogen samples, and in some cases mineral resources. WSJ Ghana, Zimbabwe, and Zambia have all rejected versions of the arrangement, while Burkina Faso accepted it in February. Telegraph TRT Afrika The split illustrates how governments across the continent are weighing near-term funding needs against longer-term concerns over sovereignty and pharmaceutical access.

Ghana's objection centers on scope. Arnold Kavaarpuo, executive director of the country's Data Protection Commission, has said Accra's concerns run to the breadth of data the US is requesting and the absence of reciprocal commitments on Ghanaian data protection and sovereignty. BBC That framing — reciprocity, or the lack of it — has become the throughline across most of the continent's rejections.

Zimbabwe's government has been more explicit about the commercial stakes. A government spokesman said Harare saw no guarantee that any drugs or vaccines developed from pathogens supplied under the deal would be made available to Zimbabweans, and pointed instead to the World Health Organization's existing framework for member states to share pathogen data and benefit from resulting treatments. BBC That WHO mechanism, built after years of negotiation partly in response to disputes over benefit-sharing during past outbreaks, is the implicit benchmark against which African governments are now measuring Washington's terms.

South Africa's Health Minister, Dr Aaron Motsoaledi, has taken the most pointed public stance. He told the BBC that no self-respecting nation should accede to the US requests, characterizing the arrangement as one in which Washington would receive pathogens from any pandemic or epidemic on African soil, along with a "genome for life," in exchange for five years of funding. BBC The "genome for life" phrasing captures the durational asymmetry critics point to: a finite aid commitment set against what they describe as an open-ended data claim.

Civil society groups have organized around the same objection. Aggrey Aluso, executive director of the Resilience Action Network Africa, joined more than 50 civil society organizations in an open letter warning African leaders that the US terms are not shaped by African national or regional interests. BBC Nelson Aghogho Evaborhene, a PhD fellow in global health governance at Roskilde University, has been among the academics tracking the negotiations as a test case for how global health data governance evolves outside WHO's multilateral channels. BBC

Washington's position is that the request is nothing new. A State Department spokesperson said the material sought is the same aggregated, de-identified data that has underpinned infectious disease surveillance for years, and that African countries have long shared comparable information through existing US-run programs, including USAID and the President's Emergency Plan for AIDS Relief. BBC That defense rests on continuity: Pepfar and USAID have operated as conduits for epidemiological data for two decades without the level of public pushback now greeting the new bilateral deals.

The dispute is unfolding as an Ebola outbreak has spread in recent weeks in the Democratic Republic of Congo, a reminder of the stakes attached to rapid pathogen-sharing protocols in the region. BBC DRC has faced repeated Ebola flare-ups over the past decade, and the speed and completeness of genomic sequencing shared internationally has historically shaped how quickly vaccine candidates and therapeutics could be deployed.

What separates this round of agreements from Pepfar-era data flows, in the view of critics, is the bundling of health data with mineral access and the absence of binding commitments on downstream access to treatments developed from African-sourced samples. Whether that distinction holds up depends partly on contract language none of the involved governments has published in full. Kenya's judicial intervention suggests the terms are, at minimum, vulnerable to domestic legal scrutiny over data protection standards — a vulnerability other governments weighing the deal are likely watching closely.

Burkina Faso's acceptance of the package in February indicates the calculus is not uniform. Governments facing more acute funding gaps, weaker domestic legal infrastructure, or different foreign policy alignments have reached different conclusions about the trade-off. The pattern emerging — split decisions rather than continent-wide consensus — means the debate over pathogen sovereignty and data reciprocity is likely to continue country by country rather than resolve through any single multilateral forum.